Vectorious Medical Technologies
Vectorious Medical Technologies developed the V-LAP, the world's first in-heart microcomputer for optimal heart disease treatment.
About
Vectorious Medical Technologies is a medical device company that has developed the V-LAP, a miniature, wireless, battery-less, digital sensory implant designed to be placed in the heart. This in-heart microcomputer aims to provide continuous, direct left atrial pressure monitoring, enabling personalized and optimal treatment for heart disease patients, thereby improving their quality of life and life expectancy. Teams look it up for Healthcare, Cardiology, Sensor.
Frequently asked
What does Vectorious Medical Technologies do?
Vectorious Medical Technologies is a Healthcare company that offers Hardware, Software. Teams look it up for Cardiology, Sensor, Heart Failure. It is based in Tel Aviv, Israel and was founded in 2011. Public records show about 114 people and $15M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Vectorious Medical Technologies raised?
Vectorious Medical Technologies has raised a total of $15M in funding. The most recent round on record is Grant.
Where is Vectorious Medical Technologies headquartered?
Vectorious Medical Technologies is headquartered in Tel Aviv, Israel.
When was Vectorious Medical Technologies founded?
Vectorious Medical Technologies was founded in 2011.
What industry does Vectorious Medical Technologies operate in?
Vectorious Medical Technologies operates in Healthcare, Cardiology, Sensor, Heart Failure, MedTech.
How many employees does Vectorious Medical Technologies have?
Vectorious Medical Technologies has approximately 114 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.